Phase 5: the 2.4mg maintenance dose (48 units) This is the maximum FDA-approved dose of semaglutide for weight management, the dose used in the pivotal STEP clinical trials that demonstrated an average of 15 to 17 percent body weight reduction
Log fasting, postprandial, and bedtime readings alongside notes on meal composition, exercise, and any symptoms
Earlier evidence points in the same direction
Well be sharing: Verified Proprietary Data: Using Patientric's unique tracking data Ines Martins will reveal what users are actually doing (not just what they say) Behavioural Insight: A decoding of what is driving these behaviours as consumer psychologist Dr Paul Marsden (CPsychol) unpacks the 'why' behind the 'what' Business Implications: Discussion of what this means for brands and businesses looking to win in the GLP-1 era Whether you are in FMCG, retail or healthcare, you cannot afford to ignore a demographic that has doubled in size in less than a year
By helping individuals feel fuller sooner and for longer periods of time, these medications can potentially reduce the frequency and severity of binge eating episodes